Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,136

Participants

Timeline

Start Date

December 31, 1997

Primary Completion Date

February 28, 2007

Study Completion Date

June 30, 2007

Conditions
Cerebral PalsyIntraventricular HemorrhagePeriventricular LeukomalaciaPulmonary EdemaAbruptio Placentae
Interventions
DRUG

magnesium sulfate

Trial Locations (17)

10019

St. Luke's - Roosevelt Hospital, New York

15213

Dept of OB/GYN Magee Womens Hospital, Pittsburgh

19102

MCP Hahnemann University, Philadelphia

27103

Forsyth Memorial Hospital, Wake Forest University School of Medicine, Winston-Salem

27599

University of North Carolina, Chapel Hill

33136

Dept of OB/GYN, University of Miami, Miami

35233

University of Alabama, Birmingham

43210

Dept of OB/GYN, Ohio State University, Columbus

44109

Case Western University, Cleveland

48201

Dept of OB/GYN, Hutzel Hospital, Detroit

60611

Northwestern University, Chicago

77030

University of Texas - Houston, Houston

77555

University of Texas Medical Branch - Galveston, Galveston

84132

University of Utah Medical Center, Salt Lake City

45267-0794

The University Hospital, University of Cincinnati, Cincinnati

02905-2499

Women and Infants Hospital, Providence

75235-9032

Dept of OB/GYN, Southwestern Medical Center, University of Texas, Dallas

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

The George Washington University Biostatistics Center

OTHER

NCT00014989 - Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) | Biotech Hunter | Biotech Hunter